Source: British Journal of Clinical Pharmacology. Unidade: ICB
Subjects: CROMATOGRAFIA LÍQUIDA, ESTRIOL, VAGINA, ENDOMÉTRIO, ESPECTROMETRIA DE MASSAS, HORMÔNIO FOLÍCULO-ESTIMULANTE, HORMÔNIOS SEXUAIS, FARMACOCINÉTICA, FARMACODINÂMICA
ABNT
OLIVEIRA FILHO, Raimundo Vieira de et al. Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women. British Journal of Clinical Pharmacology, v. 85, p. 551-562, 2019Tradução . . Disponível em: https://doi.org/10.1111/bcp.13822. Acesso em: 24 abr. 2024.APA
Oliveira Filho, R. V. de, Antunes, N. de J., Ilha, J. de O., Moreno, R. A., Wedemeyer, R. -S., Warnke, A., & De Nucci, G. (2019). Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women. British Journal of Clinical Pharmacology, 85, 551-562. doi:10.1111/bcp.13822NLM
Oliveira Filho RV de, Antunes N de J, Ilha J de O, Moreno RA, Wedemeyer R-S, Warnke A, De Nucci G. Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women [Internet]. British Journal of Clinical Pharmacology. 2019 ; 85 551-562.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1111/bcp.13822Vancouver
Oliveira Filho RV de, Antunes N de J, Ilha J de O, Moreno RA, Wedemeyer R-S, Warnke A, De Nucci G. Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women [Internet]. British Journal of Clinical Pharmacology. 2019 ; 85 551-562.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1111/bcp.13822